During the past decade, Fondazione G.B. Bietti Per Lo Studio E La Ricerca in Oftalmologia-Presidio Ospedaliero Britannico conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 5 clinical trials were completed, i.e. on average, 29.4% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 5 clinical trials were completed. i.e. 62.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Fondazione G.B. Bietti Per Lo Studio E La Ricerca in Oftalmologia-Presidio Ospedaliero Britannico" #1 sponsor was "Fondazione G.B. Bietti, IRCCS" with 7 trials, followed by "Hoffmann-La Roche" with 6 trials sponsored, "Bayer" with 2 trials sponsored, "Allergan" with 1 trials sponsored and "Apellis Pharmaceuticals, Inc." with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Fondazione G.B. Bietti Per Lo Studio E La Ricerca in Oftalmologia-Presidio Ospedaliero Britannico" #1 collaborator was "CNR Institute for chemical and physical processes (IPCF), Messina" with 1 trials as a collaborator, "Chugai Pharmaceutical" with 1 trials as a collaborator, "Fondazione G.B. Bietti, IRCCS" with 1 trials as a collaborator and "Regeneron Pharmaceuticals" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Fondazione G.B. Bietti Per Lo Studio E La Ricerca in Oftalmologia-Presidio Ospedaliero Britannico" are "Diabetic Macular Edema" (4 trials), "Diabetic Retinopathy" (3 trials), "Geographic Atrophy" (2 trials), "Central Retinal Vein Occlusion" (1 trials) and "Diabetes Mellitus" (1 trials). Many other conditions were trialed in "Fondazione G.B. Bietti Per Lo Studio E La Ricerca in Oftalmologia-Presidio Ospedaliero Britannico" in a lesser frequency.

Most popular intervention types in "Fondazione G.B. Bietti Per Lo Studio E La Ricerca in Oftalmologia-Presidio Ospedaliero Britannico" are "Drug" (14 trials), "Other" (8 trials), "Procedure" (3 trials), "Combination Product" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Sham Procedure" (7 trials), "Faricimab" (5 trials), "Aflibercept" (3 trials), "Citicoline" (3 trials) and "Placebo" (2 trials). Other intervention names were less common.

The vast majority of trials in "Fondazione G.B. Bietti Per Lo Studio E La Ricerca in Oftalmologia-Presidio Ospedaliero Britannico" are 19 trials for "All" genders.

Currently, there are NaN active trials in "Fondazione G.B. Bietti Per Lo Studio E La Ricerca in Oftalmologia-Presidio Ospedaliero Britannico". undefined are not yet recruiting, 3 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Fondazione G.B. Bietti Per Lo Studio E La Ricerca in Oftalmologia-Presidio Ospedaliero Britannico, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Fondazione G.B. Bietti Per Lo Studio E La Ricerca in Oftalmologia-Presidio Ospedaliero Britannico, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 6 trials that are defined as “Not Applicable".